Technology due diligence is the discipline of moving from a technology's story to its evidence — asking not what a company claims its technology can do, but what the record shows it has done, protected, and published.
For investors, acquirers, and corporate development teams, that distinction is consequential. A compelling demonstration and a well-funded narrative are not substitutes for a credible research base, durable intellectual property, and a realistic read of the competitive field. Getting that read right before a transaction closes is the purpose of technology due diligence.
What technology due diligence answers
At its core, technology diligence tries to answer three questions. First: is the technology real? Not a prototype or a proof-of-concept dressed as a product, but a working, reproducible capability at a meaningful scale. Second: is it defensible? Does the company have intellectual property that creates durable barriers, or is the technology easily replicated? Third: is it durable? Will this capability still matter in three, five, or ten years — or is it a transitional step that a successor technology will make obsolete?
These questions are deliberately sequenced. Defensibility is irrelevant if the technology is not real. Durability is irrelevant if it cannot be defended. Framing the work around all three before gathering evidence keeps the process anchored to what the decision actually requires.
Reading the evidence
Patent filings are usually the first port of call, and they reward careful reading. The scope of claims matters as much as the number of patents. A large portfolio built on narrow, incremental claims may provide less protection than a smaller set of broad foundational filings. Equally important is continuity: a strong IP position typically shows consistent filing activity over time, with each generation of filings building on the last. Gaps, lapses, or a sudden clustering of filings just before a transaction can all be informative.
The research base deserves equal attention. Peer-reviewed publications and preprints reveal how deeply the science has been worked through, and by whom. Independent replication — results reproduced by researchers with no affiliation to the company — is one of the strongest signals that a capability is genuine. A technology whose claims rest entirely on internal publications, or whose key papers come from a single group with commercial ties, warrants closer scrutiny.
Beyond patents and research, regulatory filings, standards-body participation, market activity, and other sources fill in the picture. A company that has engaged seriously with relevant regulatory processes, contributed to technical standards, or attracted credible licensing partners is demonstrating third-party validation that is difficult to manufacture. These signals, taken together, build a corroborated view that no single source can provide.
Assessing maturity and the competitive landscape
Technology maturity frameworks provide a useful anchor for this part of the analysis. NASA's Technology Readiness Levels, developed for aerospace programs, offer a structured scale that translates directly to commercial contexts: a technology at TRL 3 (proof of concept in a laboratory) carries very different risk from one at TRL 7 or 8 (demonstrated in an operational environment). Simon Wardley's mapping approach adds a complementary lens, situating a technology within the broader evolution from novel to commodity and revealing where the real competitive pressure will come from.
The competitive landscape analysis should consider not just direct competitors but substitution risk. The most common way a technology's value is eroded is not by a superior version of the same thing, but by a different approach that renders the question moot. A more productive framing is: what problem does this technology solve, and how many credible paths exist to solving that problem? The fewer the paths, and the further behind the alternatives are, the more defensible the position.
Red flags and disconfirming evidence
Effective technology diligence is an exercise in seeking disconfirmation. The goal is not to validate a thesis but to stress-test it — to find the evidence that would cause you to revise your view, and then to go looking for it deliberately.
Several patterns warrant close attention. A gap between the sophistication of the company's public narrative and the depth of its published technical record is a signal that the story has outrun the science. Patent claims that turn out to be narrow or already contested raise questions about the durability of any IP moat. A research base that is thin, self-referential, or difficult to reproduce independently undermines confidence in the underlying capability. And an unusually rapid surge in filing or publication activity immediately preceding a transaction can indicate that the IP position has been bolstered specifically for diligence purposes rather than built organically over time.
What is absent can be as telling as what is present. A technology category that has attracted serious academic and industrial research interest will typically show a rich, contested publication record with multiple groups approaching the problem from different angles. A category where one company's papers dominate the field almost entirely may indicate either an extraordinary lead or a niche that the broader community has concluded is not worth pursuing.
Grounding conclusions in evidence, not narrative
The final step is synthesis: returning to the three framing questions — real, defensible, durable — and answering each against what the evidence actually shows, not what the technology's proponents assert. That separation is the hardest discipline in the process. Founders and sellers are not being dishonest when they present their technology optimistically; they are doing what people do. The diligence function exists precisely to introduce a check on that optimism.
Stating confidence levels explicitly in the output is good practice. "The patent portfolio appears broad, but claims have not been tested in litigation" is more useful than either "the IP is strong" or "the IP is weak." Evidence supports degrees of confidence, and those degrees belong in the conclusion. A summary that distinguishes what the evidence shows from what the company asserts gives decision-makers the information they need to price risk rather than absorb it unknowingly.
Technology due diligence done well does not eliminate uncertainty — no amount of analysis can — but it replaces undifferentiated uncertainty with calibrated judgment. That is the outcome that matters.
Keep exploring: Practice covers the full range of applied technology-intelligence methods. How to evaluate an emerging technology walks through the broader assessment framework that technology due diligence sits within. If you are applying this in an investment context, technology intelligence for private equity shows how CanaryIQ supports that work.